Assistant Professor, University of Guelph. Editorial board, Frontiers in Respiratory Physiology
Dr. Vaisitti has been working in the field of CLL since she started her PhD program studying the role of CD38 in the biology and pathogenesis of CLL. She continued the training in hematology/oncology obtaining a 3-year fellowship from the Italian Association for Cancer Research (AIRC), with a project aimed at analysing and dissecting the molecular mechanisms regulating leukemic proliferation and homing. Dr. Vaisitti spent several periods in Italian and foreign laboratories as a visiting scientist including a period at Feinstein Institute for Medical Research, North Shore-Long Island Jewish (NY) and a period at the Dept. of Medical Biochemistry and Immunology, Cardiff University (UK). Recently, Dr. Vaisitti spent 2 years as a visiting fellow at the Weill Cornell Medical College, Dept. of Pathology and Laboratory Medicine (NY), to set up patient-derived xenograft models of CLL and Richter syndrome, and also investigate the functional impact of novel drugs.
In the last 5 years, Dr. Vaisitti’s research has been focused on two main topics. The first one is the functional analysis of genes found recurrently mutated in chronic lymphoproliferative syndromes. Attention has been focused on NOTCH1, SF3B1, BIRC3 and NOTCH2. These works were done in a joint collaboration with the group of Prof. Gaidano (University of Eastern Piedmont, Italy). The second topic is the discovery and analysis of host microenvironmental conditions that favor leukemic development and progression.
Yegor Vassetzky graduated from the Moscow State University. After a PhD thesis in molecular biology at the Engelhardt Institute of Molecular Biology in Moscow, he worked as a postdoctoral fellow in laboratories of Klaus Scherrer (Paris), Susan Gasser (Lausanne) and Marcel Méchali (Montpellier). Since 2002 he heads the laboratory of Nuclear Organization and Pathologies at Gustave Roussy Institute (Villejuif, France). His main research interests concern epigenetic regulation in cancer and neuromuscular diseases. Yegor Vassetzky is Associate Editor for Biopolymers & Cell, and member of the Editorial Board of PeerJ and Oncotarget.
Dr. Shibiao Wan is currently an Assistant Professor in the Department of Genetics, Cell Biology and Anatomy, and the Co-Director for the Bioinformatics and Systems Biology (BISB) PhD Program at University of Nebraska Medical Center (UNMC). He is also an Assistant Professor (courtesy) in the Department of Biostatistics at UNMC.
With more than 14 years of experience in machine learning, bioinformatics, and computational biology, Dr. Wan has published >50 articles in top-tiered journals such as Genome Research, Nature Communications, Science Advances, Circulation Research, Briefings in Bioinformatics, and Bioinformatics. Dr. Wan is the Editor-in-Chief for Current Proteomics, and an Editorial Board Member for a series of prestigious journals such as Briefings in Functional Genomics, Heliyon, BMC Bioinformatics, International Journal of Microbiology, PeerJ Computer Science, BioMed Research International, and Computational and Mathematical Methods, and a guest associate editor for multiple high-impact journals including Frontiers in Immunology, Frontiers in Cell and Developmental Biology, Frontiers in Pharmacology, Biology, Frontiers in Genetics, and Genes.
Dr Wan is a TPC member for >20 machine learning related international conferences including IEEE ICTAI. Dr. Wan is also a reviewer for >70 prestigious journals including Nature Biotechnology, Nature Methods, Nature Communications, Nature Computational Science, Science Advances, Nucleic Acids Research, Advanced Science, Cancer Research, Genome Biology, and Genome Medicine. Dr. Wan has received a number of accolades including the Springer Nature Editor of Distinction Award in 2025 by Springer Nature, the New Investigator Award in 2024 by UNMC, the FIRST Award in 2023 by Nebraska EPSCoR, the Outstanding Young Alumni Award in 2022 by HK PolyU as well as the Global Peer Review Awards (top 1%) in “Cross-Field” and “Biology and Biochemistry” in 2019 by Clarivate. Dr. Wan is a member of AACR, ISCB and ACM and an IEEE Senior Member.
Dr. Joshua Wolf, PhD, MBBS is an associate faculty member and clinical investigator at St. Jude Children's Research Hospital within the Department of Infectious Diseases.
His research interests include; Prediction, Prevention and Treatment of Infections in Immunocompromised Children, and the Management of Device-Associated Infections.
Dr. Wei Xu received his Ph.D. in Biostatistics from University of Toronto. He is currently a scientist and principle biostatistician in Princess Margaret Hospital on clinical research of cancer diseases. He is a faculty member at the Dalla Lana School of Public Health, University of Toronto and on the Editorial Board of the Journal of Medical Statistics and Informatics. Dr. Xu's research interests are statistical genetics and clinical trial design and analysis. He is the author or co-author of over 100 publications in peer-review journals.